by jtcir-auto | Feb 19, 2025 | Press Releases
On-demand video webcast now available here AURORA, CO / ACCESS Newswire / February 19, 2025 / Exxel Pharma (“Exxel” or the “Company”), a pharmaceutical company dedicated to developing novel therapeutics for the treatment of neuronal...
by jtcir-auto | Feb 3, 2025 | Press Releases
Refractory chronic cough represents a significant unmet need with no FDA-approved treatment options and $11B total addressable global market First-in-human Phase 1/1b single/multiple dose study in normal volunteers expected to commence enrollment in Q3/4 2025 with...
